Why Hims & Hers Health (HIMS) Is Rallying Today
By acquiring Sigmund NJ LLC, known as Trybe Labs, Hims & Hers will be able "to support at-home blood draws and more comprehensive whole body testing," HIMS reported.
Hims & Hers Health Inc. (HIMS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | Royce & Associates Chuck Royce | 0 | $0 | 0% | |
| 3. | Magnetar Capital Alec Litowitz And Ross Laser | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | Hudson Bay Capital Management Sander Gerber | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.50 | 1,000 | Director | 5,000 | 2024-11-14 | Filing | |
| $26.94 | 4,000 | Director | 4,000 | 2024-11-12 | Filing | |
| $17.74 | 110,000 | Director | 110,000 | 2024-05-21 | Filing | |
| $3.66 | 73,700 | Large Shareholder, Director | 125,000 | 2022-06-14 | Filing | |
| $3.66 | 1,300 | Large Shareholder, Director | 51,300 | 2022-06-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $59.54 | 1,493 | Large Shareholder, Officer, Director | 427,796 | 2025-02-18 | Filing | |
| $58.22 | 31,257 | Large Shareholder, Officer, Director | 429,289 | 2025-02-18 | Filing | |
| $57.85 | 14,784 | Large Shareholder, Officer, Director | 460,546 | 2025-02-18 | Filing | |
| $59.57 | 10,328 | Large Shareholder, Officer, Director | 97,687 | 2025-02-18 | Filing | |
| $58.26 | 81,660 | Large Shareholder, Officer, Director | 108,015 | 2025-02-18 | Filing |
Institutional Investors' Holdings
News See All
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Lorenzo’s 2 cents. In this article, we will summarize the bulls’ thesis on HIMS. Hims & Hers Health, Inc.
Jim Cramer Shed Light on These 8 Stocks Recently
“Look, people on Wall Street, you better start taking the President of the United States more seriously or else you're gonna keep losing money.
12 Best Beauty Stocks to Buy According to Hedge Funds
According to a report by McKinsey, in 2023, the global beauty market expanded by 10%, reaching $446 billion in retail sales, mostly due to price hikes rather than volume advances.
5 Stocks That Started The Year On A High
Anyone who’s looked at the market in the last couple of weeks will know that there were some events that shook investors.
Why These 15 Stocks Are Skyrocketing in 2025
Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward tech innovation.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on HIMS. Hims & Hers Health, Inc.
Here’s Cedar Grove Capital Management’s Investment Thesis for Hims & Hers Health (HIMS)
Cedar Grove Capital Management, an investment management company, released its fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Why Lamb Weston (LW), Hims & Hers (HIMS), and MicroStrategy Inc (MSTR) Plunged Today
Shares in Lamb Weston (LW), Hims & Hers (HIMS), and MicroStrategy Inc.
Billionaire Hedge Funds
